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Introduction
Bilobalide (BB), ginkgolide B (GB) and picrotoxin (PTX) are non-competitive inhibitors of GABA, glycine and 5-HT 3 receptors (Hadley et al., 2005; Hawthorne et al., 2006; Huang et al., 2004; Pribilla et al., 1992; Sivilotti and Nistri, 1991;  MOL #71415 Package (Department of Physiology and Pharmacology, University of Strathclyde, UK; www.strath.ac.uk/Departments/PhysPharm). Currents were filtered at a frequency of 1 kHz and sampled at 5 kHz. Micro-electrodes were fabricated from borosilicate glass (GC120TF-10, Harvard Apparatus, Edenbridge, Kent, UK) using a two stage horizontal pull (P-87, Sutter Instrument Company, California, USA) and filled with 3 M KCl. Pipette resistances ranged from 1.0 -2.0 MΩ. Oocytes were perfused with saline at a constant rate of 15 ml min -1 . Drug application was via a simple gravity fed system calibrated to run at the same rate. Extracellular saline contained (mM), 96 NaCl, 2 KCl, 1 MgCl 2 and 5mM HEPES; pH 7.4 with NaOH.
Analysis and curve fitting was performed using Prism v3.02 (GraphPad Software, San Diego, California, USA, www.graphpad.com). Concentration-response data for each oocyte was normalised to the maximum current for that oocyte. A 2 min wash was typically used between drug applications. The mean and SEM for a series of oocytes were plotted against agonist or antagonist concentration and iteratively fitted to the following equation: where A is the concentration of ligand present; I A is the current in the presence of ligand concentration A; I min is the current when A=0; I max is the maximal current, A 50 is the concentration of A which evokes a current equal to (I max + I min )/2; and n H is the Hill coefficient. Comparisons, were made by subtracting wild type log A from mutant log A, (i.e. the ratio of EC 50 or IC 50 s). K B was estimated from IC 50 values using the Cheng-Prusoff equation with the modification by Leff and Dougall (1993) . This article has not been copyedited and formatted. The final version may differ from this version. Radioligand Binding -Transfected HEK293 were scraped into 1 ml of ice-cold HEPES buffer (10 mM, pH 7.4) and frozen at -20 o C. After thawing, they were washed with HEPES buffer, homogenised, and 50 µg of crude cell membranes incubated in 0.5 ml HEPES buffer containing 1 nM [ 3 H]granisetron (~ K d ) in the presence or absence of BB (2.5 mM -0.25 nM), GB (2.5 mM -0.25 nM), DTZ (10 mM -0.1 nM)
or PXN (5 mM -0.5 nM). Non-specific binding was determined using 1 mM quipazine. Reactions were incubated for at least 1 h at 4°C and terminated by vacuum filtration using a Brandel cell harvester onto GF/B filters pre-soaked in 0.3 % polyethyleneimine. Radioactivity was determined by scintillation counting using a Beckman BCLS6500 (Fullerton, California, USA 
Results
To find the molecular determinants of BB, GB, DTZ and PXN binding, a series of mutants were generated at each of the nine channel lining M2 residues of the human 5-HT 3 A receptor subunit (Fig 1) . Residues were mostly mutated to amino acids with similar chemical properties to prevent complications arising from changes in channel gating. Conservative changes minimise the impact on receptor structure and function, but still reveal specific interactions between the receptor and antagonist (e.g. Thompson et al., 2005) . Wild type and mutant receptors (except for S2'T and S12'T which were non-functional) responded to 5-HT in a concentration-dependent manner, with EC 50 and n H values of mutants differing < 6-fold from wild type ( Table   1 , Fig 2) . Significant effects on BB inhibition were seen at residues S2', T6', L7', L9' and S12' (Table 2, Fig 3A) . The most dramatic effects were at T6'S and S12'A, where inhibition by 1 mM BB was completely abolished. Of the remaining mutants that were inhibited by BB, S2'A exhibited the greatest change in potency, with a 42-fold enhancement. L7'T showed a 6-fold enhancement and L9'V a 3-fold reduction in potency.
Effects of compounds -
Inhibition by 1 mM GB was abolished by 6' and 12' mutations, but at all other mutants except N-4' potency was increased (Table 3 , Fig 3B) . Decreases in IC 50 were generally small (< 5-fold), with the exception of S2'A, which displayed a decrease of
125-fold.
This article has not been copyedited and formatted. The final version may differ from this version. PXN inhibition was eliminated by T6'S substitution (Table 4 , Fig 3C) .
Significant pIC 50 changes were also seen at positions -4', -1', 2', 9' and 12', but effects on potency were generally small (< 5-fold), with the exceptions of L9'V and S12'A which showed reductions of 38-fold and 6-fold respectively.
The relative changes in DTZ inhibition were less than with the other three compounds (Table 5 , Fig 3D) . Most of the substitutions had no effect, although mutation of L7' and S12' caused 5-fold decreases in potency.
S2'A mutants must re-open to recover from GB inhibition -In the S2'A mutant
receptor a striking increase in both BB (42-fold) and GB (125-fold) potency was observed. For GB, but not BB, this was accompanied by ligand trap: following a coapplication of GB and 5-HT, the next response to 5-HT alone had a reduced current amplitude that only returned to the pre-treatment amplitude with a second 5-HT application. This effect is shown in figure 4, which is a representative example of 8 similar experiments on different oocytes. Peak current were stable with 5-HT alone (Fig 4A) , but, following a GB inhibition, recovery was independent of the time interval between the first (5-HT + GB) and second (5-HT alone) applications , showing that the effect was not the consequence of prolonged recovery from desensitisation. After the initial increase in current amplitude, further applications of 5-HT did not show any additional increases (Fig 4E) . Application of GB in the absence of 5-HT did not change the peak response of subsequent 5-HT applications, but was altered if GB was added at any time during 5-HT application (Figs 4F -FH).
Competition Binding: In a previous study we showed that BB, GB and PXN do not compete with granisetron (a high affinity competitive antagonist) at 5-HT 3 A or 5-HT 3 AB receptors (Thompson et al., 2011) . Here we extended these studies to include DTZ. The pK d of [ In GABA A receptors the 6' position is the main (hydrogen bonding) interacting residue and the 2' position acts as a secondary (hydrophobic) site for PTX binding (Erkkila et al., 2008) . Our results support the role of T6' as a major determinant of PXN binding, but the effect of our conserved mutation (inhibition was abolished) was more pronounced than those reported for the GABA A receptor, where changing all five of the 6' Thr residues to Ser only caused a 48-fold shift in the PTX IC 50 (Erkkila et al., 2008) . The effects of the 2' and 6' substitutions indicate that BB, GB and PXN can penetrate beyond the central 'hydrophobic girdle', which forms the 'gate' of the channel (L9' -V13'; Miyazawa et al., 2003) , and our observation that GB is trapped in the high affinity S2'A mutant is consistent with this hypothesis. 2' residues have been implicated in PTX inhibition in GABA A , GABA C , and glutamategated Cys-loop receptors, with some small effects at glycine and 5-HT 3 A receptors (Das and Dillon, 2005; Etter et al., 1999; Gurley et al., 1995; Shan et al., 2001; Wang et al., 1995; Xu et al., 1995; Zhang et al., 1995) . We propose that the decreased IC 50 s we observed for BB, GB and (to a lesser extent) PXN in the S2'A mutant may arise from the more hydrophobic side-chain of Ala enabling the ligands to adopt a more energetically favourable position within the channel, possibly via interactions with their lipophilic side chains. Ala substitutions at S12' also had large effects on BB and GB (inhibition abolished), although only moderately effected PXN. If we assume that the 6' residue is important for ligand interactions, S12' may act as a secondary binding site, or interact with antagonists as they descend into the pore. BB and PTX have mixed competitive and non-competitive behaviours in a range of Cys-loop receptors, but at least one site of action is in the receptor channel (Huang et al., 2006; Lynch et al., 1995; Wang et al., 1995; Smart and Constanti, 1986) . We have previously shown that BB, GB and PXN do not compete with The probable 'gate' region of the channel (~ 8 Å long) is boxed (Miyazawa et al., 2003) . The M2 amino acid sequence for the murine A subunit (accession number Q6J1J7) is shown, with residues that are water accessible highlighted in grey; 1 Kaneez and White, 2004 , 2 Reeves et al., 2001 , 3 Panicker et al., 2002 . m = mouse, h = human. 5-HT pEC 50 values were determined from concentration-response curves (Panel A; data = mean ± SEM, n can be found in Table 1 
